Pascal Dô
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Lung Cancer Diagnosis and Treatment 3
- Oncology 5
- Lung Cancer Research Studies 3
- Co-authors
- Charline Lasnon (4 shared papers)Nicolas Aide (4 shared papers)Cédric Desmonts (3 shared papers)CHRISTOS CHOUAID (11 shared papers)Radj Gervais (5 shared papers)Catherine Dubos‐Arvis (4 shared papers)Elske Quak (1 shared paper)Alain Vergnenégre (6 shared papers)
- Journals
- Lung Cancer (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Journal of Thoracic Oncology (3 papers)European Respiratory Journal (2 papers)The Lancet Oncology (2 papers)
- Partner nations
- FranceLuxembourgItaly
In The Last Decade
Pascal Dô
28 papers receiving 1.2k citations
Pascal Dô's Hit Papers
Peers
Comparison fields: 5 of 58
- Otorhinolaryngology 113
- Pulmonary and Respiratory Medicine 705
- Oncology 374
- Radiology, Nuclear Medicine and Imaging 208
- Cancer Research 115
Countries citing papers authored by Pascal Dô
This map shows the geographic impact of Pascal Dô's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Dô with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Dô more than expected).
Fields of papers citing papers by Pascal Dô
This network shows the impact of papers produced by Pascal Dô. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Dô. The network helps show where Pascal Dô may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Dô, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial Hit paper breakdown → | 2019 | 364 |
| 2 | Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial Hit paper breakdown → | 2021 | 157 |
| 3 | 2014 | 145 | |
| 4 | 2013 | 102 | |
| 5 | 2015 | 68 | |
| 6 | 2016 | 49 | |
| 7 | 2016 | 37 | |
| 8 | 2018 | 36 | |
| 9 | 2017 | 33 | |
| 10 | 2018 | 31 | |
| 11 | 2017 | 29 | |
| 12 | 2017 | 26 | |
| 13 | 2019 | 22 | |
| 14 | 2017 | 20 | |
| 15 | 2020 | 19 | |
| 16 | 2016 | 19 | |
| 17 | 2015 | 16 | |
| 18 | 2016 | 16 | |
| 19 | 2019 | 14 | |
| 20 | 2017 | 11 |
About Pascal Dô
Pascal Dô is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Otorhinolaryngology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Medical Imaging Techniques and Applications (4 papers), Lung Cancer Research Studies (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Cancer Genomics and Diagnostics (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Otorhinolaryngology (113 citations), Pulmonary and Respiratory Medicine (705 citations), Oncology (374 citations), Radiology, Nuclear Medicine and Imaging (208 citations) and Cancer Research (115 citations). Pascal Dô has collaborated with scholars based in France, Luxembourg and Italy. Frequent co-authors include Charline Lasnon, Nicolas Aide, Cédric Desmonts, CHRISTOS CHOUAID, Radj Gervais, Catherine Dubos‐Arvis, Elske Quak, Alain Vergnenégre, J.B. Auliac and Jeannick Madelaine. Their work appears in journals such as Lung Cancer, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Thoracic Oncology, European Respiratory Journal and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.